Perceptive Advisors LLC 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 9:50 pm Purchase | 2024-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Perceptive Advisors LLC | 5,435,210 8.600% | 291,635 (+5.67%) | Filing |
| 2024-04-17 4:15 pm Purchase | 2024-04-15 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | Perceptive Advisors LLC | 5,143,575 8.300% | 1,874,996 (+57.36%) | Filing |
| 2024-04-03 6:18 pm Unchanged | 2024-04-01 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | Perceptive Advisors LLC | 3,268,579 5.400% | 0 (Unchanged) | Filing |
| 2024-03-20 5:51 pm Purchase | 2024-03-13 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | Perceptive Advisors LLC | 3,268,579 5.400% | 8,566 (+0.26%) | Filing |
| 2024-02-12 4:16 pm Purchase | 2024-02-01 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Perceptive Advisors LLC | 3,260,013 5.500% | 3,260,013 (New Position) | Filing |